Myocet
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Myocet, covering 2009-02-23 to 2024-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer [Phase 2]